Jaguar Health (JAGX) Inventory (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Inventory of $7.8 million for Q1 2026, down 25.92% year-over-year from $10.6 million in Q1 2025, and down 9.07% quarter-over-quarter from $8.6 million in Q4 2025.
Jaguar Health (JAGX) Inventory (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Inventory for 13 consecutive years, with $7.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory fell 25.92% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $7.8 million (down 25.92% YoY), while the FY2025 annual figure was $8.6 million, down 16.88% from the prior year.
- Inventory retreated to $7.8 million in Q1 2026 per JAGX's latest filing, from $8.6 million in the prior quarter.
- Across five years, Inventory topped out at $10.7 million in Q2 2025 and bottomed at $4.9 million in Q1 2022.
- Historically, Inventory has averaged $8.6 million across 5 years, with a median of $8.7 million in 2023.
- Annual changes were most pronounced in 2022 — Inventory surged 98.27% — and 2026, when it fell 25.92%.
- Jaguar Health's Inventory stood at $7.0 million in 2022, then jumped by 30.82% to $9.2 million in 2023, then gained by 12.58% to $10.3 million in 2024, then slipped by 16.88% to $8.6 million in 2025, then declined by 9.07% to $7.8 million in 2026.
- Business Quant data shows JAGX's Inventory at $7.8 million in Q1 2026, $8.6 million in Q4 2025, and $10.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Jaguar Health | 452,552.38 | -9.61 Mn | 19.11 Mn | 7.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.82 Mn |
| Dec 31, 2025 | 8.60 Mn |
| Sep 30, 2025 | 10.63 Mn |
| Jun 30, 2025 | 10.72 Mn |
| Mar 31, 2025 | 10.56 Mn |
| Dec 31, 2024 | 10.35 Mn |
| Sep 30, 2024 | 9.67 Mn |
| Jun 30, 2024 | 9.56 Mn |
| Mar 31, 2024 | 9.02 Mn |
| Dec 31, 2023 | 9.19 Mn |
| Sep 30, 2023 | 8.38 Mn |
| Jun 30, 2023 | 8.26 Mn |
| Mar 31, 2023 | 8.68 Mn |
| Dec 31, 2022 | 7.02 Mn |
| Sep 30, 2022 | 6.60 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 4.88 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Sep 30, 2021 | 4.51 Mn |
| Jun 30, 2021 | 3.40 Mn |